Research subjects were patients diagnosed High grade B-cell lymphoma with MYC and BCL2 and / or BCL6 rearrangements by FISH and HGBL, NOS at Blood Transfusion and Hematology Hospital within 24 months from 01/06/2018 - 31/05/2020.